NCT01644968

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I 

NCT01552681

Baminercept in Sjögren's Syndrome

Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II

NCT01489956

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) 
Phase 0 

2008-001974-33

mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Conditions: Uveal Melanoma 
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a

NCT00774943

A Study of AMG 557 in Adults With Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus
Sponsors: Amgen
Phase I

NCT00643097

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II

PA16215

Immune response to neoantigen and recall antigen in pediatric renal transplant recipients treated with the IL-2Rα monoclonal antibody, daclizumab (Zenapax)

Condition: Renal Transplant
Sponsors: Hoffman-La Roche Inc.
Phase: IV

NCT00282308

A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate

Conditions: Rheumatoid Arthritis
Sponsors: Genentech
Phase II

NCT00135681

Immune Dysregulation in Children and Adults With Asthma

Conditions: Asthma, Lung Diseases
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Phase n/a 

2004-004774-85

A Multicenter Study to Evaluate the Effect of Rituximab (IDEC-102) on Primary Humoral Response, Recall Response, and Maintenance of Acquired Immunity to Specific Antigens

Conditions: Non-Hodgkin’s Lymphoma
Sponsors: Biogen Idec Inc
Phase n/a